Compare MRKR & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRKR | ABTS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 7.4M |
| IPO Year | 2010 | 2021 |
| Metric | MRKR | ABTS |
|---|---|---|
| Price | $1.33 | $2.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.25 | N/A |
| AVG Volume (30 Days) | 123.0K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $1.35 |
| 52 Week High | $4.07 | $10.86 |
| Indicator | MRKR | ABTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 43.15 |
| Support Level | $0.83 | $2.06 |
| Resistance Level | $1.44 | $4.75 |
| Average True Range (ATR) | 0.12 | 0.31 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 5.65 | 51.64 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.